Cullinan Therapeutics announced that it will present updated clinical data for its T cell engager therapies CLN-049 and velinotamig at the 68th ASH Annual Meeting in December 2026. CLN-049, targeting FLT3 for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), showed promising anti-leukemic activity and safety in Phase 1 trials. Velinotamig, targeting BCMA for autoimmune cytopenias, is being studied for immune thrombocytopenia and warm autoimmune hemolytic anemia. These presentations highlight Cullinan's progress in developing novel immunotherapies for cancer and autoimmune diseases, with further clinical trials underway.
Cullinan Therapeutics' presentations at the 68th ASH Annual Meeting provide context for readers interested in health sector developments. For readers following the health sector, here is Pluang's market snapshot as of Nov 04, 2026 20:41 WIB: out of 150 priced US health stocks, 127 rose and 19 fell. Notable movers include HCA Health Inc at USD 496.00 with a 7.16% increase and a typical hold time of 77 days, Medline Inc. Class A at USD 36.51 with a 7.10% rise and 98% buy order activity, and Tenet Healthcare Corporation at USD 282.52 with a 5.94% decrease and 100% sell order activity. The most notable figure is the 98% buy order activity for Medline Inc.
Kelly Technology + Motion Recruitment, a division of Kelly Services, has been recognized as a Leader on Everest Group's 2026 U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix® for its expertise in specialized IT staffing, consulting, and ...
Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...
etoro has agreed to acquire LB Finanzas, a leading Argentine all-in-one financial app, to strengthen its presence in Latin America's fast-growing fintech market. LB Finanzas offers integrated investing and payment solutions, catering to Argentine ret...
JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...
KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...
